$9.16
0[0.00%]
Last update: 4:00PM Get Real Time Here
Centessa Pharmaceuticals
(NASDAQ:CNTA)Latest News for Centessa Pharmaceuticals Stock (NASDAQ:CNTA)
Centessa Pharmaceuticals Stock (NASDAQ: CNTA)
Categories: All
Wednesday, April 24, 2024
Tuesday, April 23, 2024
Monday, April 01, 2024
Thursday, March 28, 2024
Friday, February 09, 2024
- Centessa Pharmaceuticals shares are trading higher after the company presented data from an additional 52-weeks of continuous treatment from the third year of the ongoing Phase 2a study of SerpinPC for the treatment of hemophilia.Benzinga Newsdesk - Feb 9, 2024, 2:50PM
- Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Feb 9, 2024, 1:18PM
- SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On FridayAvi Kapoor - Feb 9, 2024, 10:31AM
- Centessa Pharmaceuticals To Present Additional 52-Weeks Continuous Treatment Data From Third Year Ongoing Phase 2a Study Of SerpinPC For Treatment of Hemophilia At 17th Annual Congress Of European Association For Haemophilia And Allied DisordersBenzinga Newsdesk - Feb 9, 2024, 7:09AM
Monday, November 27, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Nov 27, 2023, 4:31PM
- Anaptys Expands Immune Cell Modulator Pipeline With Exclusive License To BDCA2 Modulator Antibody Portfolio From Centessa Pharmaceuticals; Anaptys Will Pay Centessa A One-Time Upfront Cash Payment Of $7MBenzinga Newsdesk - Nov 27, 2023, 4:16PM
Wednesday, November 15, 2023
- Centessa Pharmaceuticals shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $4 to $11.Benzinga Newsdesk - Nov 15, 2023, 1:00PM
- Jefferies Upgrades Centessa Pharmaceuticals to Buy, Raises Price Target to $11Benzinga Newsdesk - Nov 15, 2023, 6:23AM
Monday, November 13, 2023
Thursday, November 02, 2023
Tuesday, October 31, 2023
Thursday, October 26, 2023
Wednesday, October 25, 2023
Tuesday, August 15, 2023
- Where Centessa Pharmaceuticals Stands With AnalystsBenzinga Insights - Aug 15, 2023, 4:00PM
- SVB Securities Maintains Outperform on Centessa Pharmaceuticals, Raises Price Target to $11Benzinga Newsdesk - Aug 15, 2023, 12:55PM
- Guggenheim Maintains Buy on Centessa Pharmaceuticals, Raises Price Target to $10Benzinga Newsdesk - Aug 15, 2023, 11:30AM
- Goldman Sachs Maintains Neutral on Centessa Pharmaceuticals, Raises Price Target to $5Benzinga Newsdesk - Aug 15, 2023, 8:44AM
Tuesday, July 25, 2023
Thursday, July 13, 2023
Wednesday, July 12, 2023
Wednesday, June 21, 2023
Monday, June 12, 2023
Monday, May 22, 2023
- Centessa Pharmaceuticals shares are trading higher after the company received Fast Track Designation from the FDA for its treatment of hemophilia B.Benzinga Newsdesk - May 22, 2023, 8:06AM
- The FDA Granted Fast Track Designation To Centessa Pharmaceuticals' SerpinPC For Hemophilia BBenzinga Newsdesk - May 22, 2023, 7:03AM